Not Tagged
Not Tagged
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'epoetin', 'rituximab', 'epoetin,biosimilar', 'bevacizumab', 'infliximab', 'pegfilgrastim', 'filgrastim', 'derm', 'ritux', 'hidradenitis']
#ddw2023 day 2 kicking off with a deep dive into the past future of anti-tnf by shared decision making on route of administration eim benefit is strong biosimilar cost savings anti-tnf will continue to be a heavily utilized treatment 
Girl Mom🌸| IBD APN @uchicagoibd |Ostomy Specialist |Gastroenterology  APP Leader|DNP/MPH student @JHUNursing |🩺 Posts ≠ medical advice